A great announcement from NOX, I consider them reputable and this is a left field bonus to the underlying value in their very promising cancer treatments. they were arguably undervalued, although cash poor. I expect this opportunity may quickly find partners on a non dilutive basis given the urgency of large pharmas and governments to seek treatment options.
at 27c the market cap is sub $40m, this is minuscule given their cancer opportunity, let alone the Covid upside.
I hope they are successful from both a financial and moral view.
- Forums
- ASX - By Stock
- NOX
- Ann: Noxopharm Investigating Potential COVID-19 Treatment
Ann: Noxopharm Investigating Potential COVID-19 Treatment, page-19
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.009(9.38%) |
Mkt cap ! $30.68M |
Open | High | Low | Value | Volume |
9.6¢ | 10.5¢ | 9.6¢ | $3.808K | 37.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10937 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 36068 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10937 | 0.096 |
3 | 110989 | 0.091 |
1 | 99321 | 0.090 |
1 | 100000 | 0.086 |
1 | 100000 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 36068 | 2 |
0.110 | 24430 | 3 |
0.115 | 90513 | 2 |
0.120 | 96624 | 2 |
0.125 | 343081 | 7 |
Last trade - 15.59pm 02/09/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |